Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)

• Main Authors: Loretta A. Williams (Author), Meagan S. Whisenant (Author), Tito R. Mendoza (Author), Angela E. Peek (Author), Donna Malveaux (Author), Donna K. Griffin (Author), Darcy A. Ponce (Author), Bruno Palma Granwehr (Author), Ajay Sheshadri (Author), Katherine A. Hutcheson (Author), Sara M. Ali (Author), Susan K. Peterson (Author), John V. Heymach (Author), Charles S. Cleeland (Author), Ishwaria M. Subbiah (Author)
• Format: Book
• Published: SpringerOpen, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Symptom expression in SARS-CoV-2 infection (COVID-19) may affect patients already symptomatic with cancer. Patient-reported outcomes (PROs) can describe symptom burden during the acute and postacute stages of COVID-19 and support risk stratification for levels of care. At the sta...